KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to -$313.3 million.

  • Idexx Laboratories' Cash from Financing Activities fell 767.44% to -$313.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.0 billion, marking a year-over-year decrease of 3947.2%. This contributed to the annual value of -$878.1 million for FY2024, which is 9866.08% down from last year.
  • Latest data reveals that Idexx Laboratories reported Cash from Financing Activities of -$313.3 million as of Q3 2025, which was down 767.44% from -$165.6 million recorded in Q2 2025.
  • Idexx Laboratories' 5-year Cash from Financing Activities high stood at -$13.5 million for Q1 2022, and its period low was -$330.3 million during Q1 2025.
  • Moreover, its 5-year median value for Cash from Financing Activities was -$151.0 million (2023), whereas its average is -$168.3 million.
  • As far as peak fluctuations go, Idexx Laboratories' Cash from Financing Activities crashed by 4176331.66% in 2021, and later surged by 8960.29% in 2022.
  • Idexx Laboratories' Cash from Financing Activities (Quarter) stood at -$165.8 million in 2021, then grew by 29.61% to -$116.7 million in 2022, then grew by 12.75% to -$101.8 million in 2023, then tumbled by 128.57% to -$232.8 million in 2024, then plummeted by 34.59% to -$313.3 million in 2025.
  • Its Cash from Financing Activities was -$313.3 million in Q3 2025, compared to -$165.6 million in Q2 2025 and -$330.3 million in Q1 2025.